-+ 0.00%
-+ 0.00%
-+ 0.00%

Recursion Pharmaceuticals: Tempus AI will pay the company $12 million in license fees.

智通財經·09/21/2026 13:17:26
語音播報
Recursion Pharmaceuticals: Tempus AI will pay the company $12 million in license fees.